| 10429391 |
Biomarkers for cholangiocellular carcinoma (CCC) |
Barbara Sitek, Helmut E. Meyer, Dominik Megger, Thilo Bracht, Juliet Padden +2 more |
2019-10-01 |
| 8735076 |
Targets for use in diagnosis, prognosis and therapy of cancer |
Charis Eng |
2014-05-27 |
| 8163493 |
Targets for use in diagnosis, prognosis and therapy of cancer |
Charis Eng |
2012-04-24 |
| 8071299 |
Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
Bertram Müller-Myhsok, Manfred Uhr, Susanne Lucae, Daria Salyakina, Florian Holsboer |
2011-12-06 |
| 7928128 |
Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
Gerd Bartoszyk, Hermann Russ, Christoph Seyfried |
2011-04-19 |
| 7872030 |
Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
Gerd Bartoszyk, Herman Russ, Christoph Seyfried |
2011-01-18 |
| 7770002 |
Multi-factor authentication |
— |
2010-08-03 |
| 7670775 |
Method for differentiating malignant from benign thyroid tissue |
Charis Eng |
2010-03-02 |
| 7618988 |
Use of substituted aminomethyl chromans |
Henning Bottcher, Ralf Devant, Gerd Bartoszyk, Hermann Russ, Christoph Seyfried |
2009-11-17 |
| 6218140 |
Enhancer for eukaryotic expression systems |
Bernhard Fleckenstein, Walter E. Schaffner, Karoline Dorsch-Hasler, Gerhard Jahn, Michael Boshart |
2001-04-17 |
| 5849522 |
Enhancer for eukaryotic expression systems |
Bernhard Fleckenstein, Walter E. Schaffner, Karoline Dorsch-Hasler, Gerhard Jahn, Michael Boshart |
1998-12-15 |
